Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

<p>Abstract</p> <p>Background</p> <p>Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeuti...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mayr Martina, Becker Karen, Schulte Nadine, Belle Sebastian, Hofheinz Ralf, Krause Annekatrin, Schmid Roland M, Röcken Christoph, Ebert Matthias P
Format: Artigo
Langue:Inglês
Publié: BMC 2012-12-01
Collection:BMC Cancer
Sujets:
Imatinib
PDGF
Gastric cancer
Chemotherapy
Accès en ligne:http://www.biomedcentral.com/1471-2407/12/587
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires